-

Defining plasma cell diversity in human tissues

Project type

  • PhD

Project details

Plasma cells secrete antibodies that are essential for protective immunity. Plasma cells have long been known to reside in lymphoid organs such as the spleen and bone marrow, but it has been more recently discovered that these cells are found in many non-lymphoid organs, including the gut, central nervous system, fat, and skin. We have coined the term “tissue resident plasma cells” (TrPCs) to describe these specialised populations of immune cells. Each TrPC type appears to be unique, as they adapt their gene expression and antibody production to their specific tissue microenvironment, and we hypothesise that these TrPCs will make local contributions to tissue immunity.

This project will focus on analysing TrPCs from donated human tissue and apply advanced flow cytometry and genomics techniques, with the goal of getting a better understanding of the diversity of TrPCs in humans and the factors that maintain their unique gene expression and survival attributes. We aim to apply this knowledge to better understand how and why the immune system sometimes attacks its own tissues resulting in autoimmune diseases such as Lupus and Sjogren’s syndrome.

About our research group

Our laboratory studies how the development of immune cells is controlled. Maturing immune cells have many decisions to make from deciphering the early signals that initiate their formation from rare blood stem cells, through to strategic responses in the body about whether to ignore or attack foreign organisms.

Our overarching aim is to gain an understanding of how our immune system is set up and pinpoint what goes wrong in diseases of rogue immune cells such as autoimmunity and blood cell cancers. We aim to use this knowledge to discover new approaches to treat these diseases. This project is part of the Snow Centre for Immune Health, a joint initiative between WEHI and the Royal Melbourne Hospital. The centre unites leading researchers and clinicians to transform understanding of immune diseases and accelerate discovery and translation to improve patient care.

Education pathways